Davine Sijnave Selected Research

Y-39983

2/2014

AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Davine Sijnave Research Topics

Disease

3	Glaucoma 05/2015 - 12/2013
2	Cicatrix (Scar) 09/2015 - 12/2013
2	Inflammation (Inflammations) 09/2015 - 12/2013
2	Blister (Bulla) 05/2015 - 12/2013
1	Burns 09/2015
1	Corneal Neovascularization 09/2015
1	Corneal Injuries 09/2015
1	Fibrosis (Cirrhosis) 05/2015
1	Choroidal Neovascularization 05/2015
1	Hyperemia 02/2014

Drug/Important Bio-Agent (IBA)

2	rho-Associated KinasesIBA 09/2015 - 02/2014
2	CollagenIBA 09/2015 - 12/2013
1	Protein Kinases (Protein Kinase)IBA 09/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2015
1	AlkaliesIBA 09/2015
1	fluorescein isothiocyanate dextranIBA 05/2015
1	Bevacizumab (Avastin)FDA Link 05/2015
1	AntibodiesIBA 05/2015
1	Oxygen (Dioxygen)IBA 05/2015
1	Y-39983IBA 02/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2013

Therapy/Procedure

2	Filtering Surgery 05/2015 - 12/2013
1	Lasers (Laser) 05/2015
1	Intracameral Injection 12/2013
1	Trabeculectomy (Trabeculoplasty) 12/2013